Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Nov-21 10:00 AM View:  | Flexion Therapeutics, Inc. (FLXN) | 19-Nov-21 | Disposition | 30,680 | $8.50 | $260,780.00 | (100%) 30.68K to 0 | (7%) |
| 07-Sep-21 4:01 PM View: | Cellectar Biosciences, Inc. (CLRB) | 03-Sep-21 | Market Purchase | 19,417 | $1.04 | $20,244.20 | 100% 0 to 19.42K | (1%) |
| 03-Jun-21 4:20 PM View: | Flexion Therapeutics, Inc. (FLXN) | 01-Jun-21 | Grant | 28,000 | -- | -- | 1045% 2.68K to 30.68K | |
| 24-Feb-21 12:08 PM View: | Marshall Edwards Inc. (MEIP) | 23-Feb-21 | Market Sale | 25,000 | $4.03 | $100,625.00 | (40%) 62.5K to 37.5K | < 1% |
| 13-Aug-20 4:31 PM View: | Immunitybio, Inc. (IBRX) | 11-Aug-20 | Market Sale | 65,300 | $10.23 | $668,052.00 | (37%) 174.53K to 109.23K | (131%) |
| 20-Dec-19 12:56 PM View: | Marshall Edwards Inc. (MEIP) | 19-Dec-19 | Private Purchase | 62,500 | $1.60 | $100,000.00 | 100% 0 to 62.5K | |
| 07-Jun-19 4:41 PM View: | Immunitybio, Inc. (IBRX) | 06-Jun-19 | Grant | 92,592 | -- | -- | 113% 81.94K to 174.53K | |
| 11-Jun-18 4:16 PM View: | Immunitybio, Inc. (IBRX) | 07-Jun-18 | Grant | 27,322 | -- | -- | 50% 54.62K to 81.94K | |
| 20-Sep-17 5:35 PM View: | Immunitybio, Inc. (IBRX) | 18-Sep-17 | Grant | 54,621 | -- | -- | 100% 0 to 54.62K | |
| 24-Mar-17 4:24 PM View: | Flexion Therapeutics, Inc. (FLXN) | 23-Mar-17 | Option Exercise | 3,000 | $7.89 | $23,658.30 | 39% 7.78K to 10.78K | |
| 24-Mar-17 4:24 PM View: | Flexion Therapeutics, Inc. (FLXN) | 23-Mar-17 | Market Option Sale (Planned) | 3,000 | $23.00 | $69,000.00 | (28%) 10.78K to 7.78K | 60% |
| 02-Mar-17 4:56 PM View: | Flexion Therapeutics, Inc. (FLXN) | 28-Feb-17 | Option Exercise | 30,000 | $7.89 | $236,583.00 | 268% 11.21K to 41.21K | |
| 02-Mar-17 4:56 PM View: | Flexion Therapeutics, Inc. (FLXN) | 28-Feb-17 | Market Option Sale (Planned) | 30,000 | $19.97 | $599,102.00 | (73%) 41.21K to 11.21K | 54% |
| 02-Mar-17 4:56 PM View: | Flexion Therapeutics, Inc. (FLXN) | 28-Feb-17 | Market Sale (Planned) | 3,434 | $19.97 | $68,577.20 | (31%) 11.21K to 7.78K | 54% |
| 27-Dec-16 5:00 PM View: | Flexion Therapeutics, Inc. (FLXN) | 20-Dec-16 | Acquisition (other) | 1,134 | $9.01 | $10,217.30 | 12% 9.4K to 10.53K | |
| 24-May-16 5:25 PM View: | Flexion Therapeutics, Inc. (FLXN) | 20-May-16 | Acquisition (other) | 963 | $8.92 | $8,589.96 | 11% 8.43K to 9.4K | |
| 18-May-16 5:23 PM View: | Flexion Therapeutics, Inc. (FLXN) | 17-May-16 | Market Purchase | 2,500 | $9.87 | $24,668.00 | 42% 5.93K to 8.43K | (17%) |
| 17-May-16 6:12 PM View: | Flexion Therapeutics, Inc. (FLXN) | 16-May-16 | Market Purchase | 2,500 | $9.19 | $22,971.80 | 73% 3.43K to 5.93K | (11%) |
| 27-May-15 3:10 PM View: | Flexion Therapeutics, Inc. (FLXN) | 20-May-15 | Acquisition (other) | 1,311 | $11.91 | $15,614.00 | 91% 1.44K to 2.75K | |
| 26-Nov-14 5:16 PM View: | Flexion Therapeutics, Inc. (FLXN) | 20-Nov-14 | Acquisition (other) | 1,443 | $11.91 | $17,186.10 | 100% 0 to 1.44K | |
| 11-Aug-11 9:11 AM View: | Novavax, Inc. (NVAX) | 09-Aug-11 | Market Purchase | 20,000 | $1.18 | $23,600.00 | 100% 0 to 20.0K | 7% |
| 25-Aug-09 1:53 PM View: | Novavax, Inc. (NVAX) | 24-Aug-09 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 07-Jan-09 5:14 PM View: | Genelabs Technologies Inc. (GNLB) | 07-Jan-09 | Disposition (change in control) | 22,188 | $1.30 | $28,844.40 | (100%) 22.19K to 0 | 0% |
| 07-Jan-09 4:30 PM View: | Genelabs Technologies Inc. (GNLB) | 06-Jan-09 | Disposition (other) | 230,000 | $1.30 | $299,000.00 | (100%) 230.0K to 0 | 0% |
| 06-Nov-08 2:05 PM View: | Genelabs Technologies Inc. (GNLB) | 05-Nov-08 | Acquisition (other) | 15,298 | $0.54 | $8,192.08 | 222% 6.89K to 22.19K | 132% |
| 28-Nov-07 4:33 PM View: | Genelabs Technologies Inc. (GNLB) | 28-Nov-07 | Market Purchase | 6,890 | $1.45 | $9,990.50 | 100% 0 to 6.89K | (20%) |
| 19-Jul-05 3:56 PM View: | Oxigene Inc. (OTLC) | 15-Jul-05 | Grant | 80,000 | -- | -- | 182% 44.0K to 124.0K | |
| 20-May-04 10:00 PM View: | Oxigene Inc. (OTLC) | 20-May-04 | Grant | 2,000 | $7.31 | $14,620.00 | 5% 40.0K to 42.0K | (100%) |